NCT01501110View on ClinicalTrials.gov

Effects of N-acetylcysteine on Low T3 Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

November 30, 2013

Conditions
Acute Myocardial InfarctionEuthyroid Sick SyndromeIschemic Heart Disease
Interventions
DRUG

N-acetylcysteine

in infusion of 1200 mg of n-acetylcysteine twice a day for 48 hours

Trial Locations (2)

90540001

Hospital de Clínicas de Porto Alegre, Porto Alegre

Instituto de Cardiologia, Porto Alegre

All Listed Sponsors
collaborator

Hospital de Clinicas de Porto Alegre

OTHER

collaborator

Programa de pós-graduação em endocrinologia

UNKNOWN

lead

Federal University of Rio Grande do Sul

OTHER

NCT01501110 - Effects of N-acetylcysteine on Low T3 Syndrome | Biotech Hunter | Biotech Hunter